null

Please note: Anew Health is a private company focused on eating disorder treatment and does not trade under the symbol AVG. The symbol AVG was historically associated with Avast Technologies, a cybersecurity company acquired by Gen Digital in 2021. Below are the major services provided by Anew Health:

• Comprehensive Treatment Programs: Anew Health offers various levels of care for eating disorders, including Partial Hospitalization Programs (PHP) and Intensive Outpatient Programs (IOP), integrating medical, psychological, and nutritional support.
• Individual Therapy: They provide one-on-one psychotherapy sessions with licensed therapists specializing in eating disorders.
• Group Therapy: The company facilitates support groups and therapeutic sessions to foster connection and shared recovery experiences among peers.
• Nutritional Counseling: Registered dietitians offer guidance and support to help individuals develop healthy eating patterns and relationships with food.
• Medical Monitoring: Anew Health collaborates with medical professionals to address and manage the physical health impacts of eating disorders.

Information regarding the major customers of "Anew Health" (symbol: AVG) cannot be provided as this company does not appear to be a real, publicly traded entity with the specified name and stock symbol.

Publicly traded companies are required to disclose significant customers in their financial filings (e.g., 10-K reports) if those customers account for a material portion of revenue. A thorough search for "Anew Health" as a public company with the ticker "AVG" did not yield any results for an active, distinct entity.

null

Brian Adams, President & CEO

Brian Adams serves as the President & CEO of AnewHealth. He was previously the CFO, Co-President, and then President & CEO of Tabula Rasa HealthCare (TRHC), which merged with ExactCare in 2023 to form AnewHealth. Adams joined CareKinesis, TRHC's PACE pharmacy, in 2011, and started his career in the hospice sector in 2004, also having worked at KPMG. He was recognized as CFO of the Year by the Philadelphia Business Journal in 2020.

Marty Butler, Chief Financial Officer

Marty Butler is the Chief Financial Officer of AnewHealth. Before the merger that created AnewHealth, Butler served as CFO of ExactCare for over a decade, guiding its expansion from a local pharmacy to a national healthcare company. He was also the CEO of a Cleveland Clinic startup focused on health coaching and held Vice President positions in operations, integration, and analytics for a worksite health company acquired by Walgreens in 2008. His career also includes roles at Eaton Corporation, Deloitte, and PwC.

Aly Kayne, Chief Legal Officer

Aly Kayne serves as the Chief Legal Officer for AnewHealth.

Tony Casanova, Chief Information Officer

Tony Casanova holds the position of Chief Information Officer at AnewHealth.

Michael Greenhalgh, RPh, MBA, Chief Operating Officer & President, Pharmacy Services

Michael Greenhalgh is the Chief Operating Officer & President, Pharmacy Services at AnewHealth.

null

Anew Health (symbol: AVG) primarily operates in the United States, providing pharmacy care management services for individuals with complex, chronic medical needs. The company offers a suite of solutions including clinical pharmacy services, proprietary science-based technologies for medication management, national fulfillment and dispensing services, pharmacy benefit management (PBM), and support services for the Program of All-Inclusive Care for the Elderly (PACE).

The addressable markets for Anew Health's main products and services in the U.S. are:

• Pharmacy Benefit Management (PBM): The U.S. pharmacy benefit management market size was estimated at $479.22 billion in 2023. This market is projected to reach $838.43 billion by 2032, with a compound annual growth rate (CAGR) of 6.4% from 2024 to 2032.
• Medication Management: The U.S. medication management market was valued at $1.5 billion in 2022 and is expected to grow to $7.8 billion by 2032, exhibiting a CAGR of 18.2% from 2023 to 2032.
• Home Healthcare Services (related to medication dispensing and chronic care): The U.S. home healthcare market size was valued at $132.09 billion in 2022 and is projected to reach $310.49 billion by 2032, with a CAGR of 9.2% from 2023 to 2032. Anew Health provides pharmacy care nationwide to more than 100,000 Medicare and Medicaid beneficiaries, including those in home and community settings.

Here are 3-5 expected drivers of future revenue growth for Anew Health (symbol: AVG) over the next 2-3 years:

1. Expansion of Service Centers: Anew Health Ltd. (AVG) plans to raise capital through an IPO to expand its service centers, primarily in Hong Kong, and potentially into mainland China and other international markets, through both organic growth and strategic acquisitions.
2. Development of New Pain Management Devices: The company intends to use IPO proceeds to develop new pain management devices, which could introduce new revenue streams and enhance its service offerings.
3. Leveraging Growth in the Traditional Chinese Medicine (TCM) Market: Anew Health operates within the Traditional Chinese Medicine market, which is projected to grow significantly. The global TCM market is estimated at $86 billion in 2025 and is forecasted to exceed $124 billion by 2030, representing a Compound Annual Growth Rate (CAGR) of 7.5%. By expanding its footprint and offerings, Anew Health aims to capitalize on this growing market demand.

Share Issuance

• Anew Health plans to raise $20 million through its initial public offering (IPO), offering 5 million shares at a proposed price of $4.00 per share.
• The company intends to list its shares on the Nasdaq stock exchange under the ticker symbol AVG.
• Upon its IPO, Anew Health is projected to achieve a market value of $220 million at the proposed offering price.

Capital Expenditures

• Anew Health has demonstrated light capital expenditures in its recent spending, as indicated by its capital spending results compared to operating cash flow.
• The company plans to utilize the proceeds from its IPO to expand its service center network in Hong Kong and potentially into mainland China.
• A portion of the IPO funds is also earmarked for the development of new pain management devices.